We recently published a list of 10 Best Affordable Dividend Stocks to Buy According to Hedge Funds. In this article, we are ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

(NYSE:PFE) shareholders, since the share price is down 43% in the last three years, falling well short of the market return ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Zacks Research raised its Q3 2025 earnings estimate for Pfizer from $0.83 to $0.90 per share. Analysts predict full-year ...

Equities researchers at Zacks Research raised their Q3 2025 earnings estimates for Pfizer in a report issued on Monday, February 24th. Zacks Research analyst K. Shah now forecasts that the ...

Pfizer’s earnings have been struggling for the past three years, with its stock down 43%, well behind the market’s 38% return. Over the last three years, Pfizer’s earnings per share (EPS) dropped 29% ...

I asked the rheumatologist if it could be linked to the Pfizer vaccine and booster, and she said, ‘Yes, and you’re not the only patient I have who’s had this sequence of ...

Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...

Shares of Pfizer (NYSE:PFE) have delivered negative returns since I started covering the stock and the last four months have not been great either as it is down another 12% since my previous ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...